Clinical Trials for HER2-positive Advanced Breast Cancer

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

NCT ID: NCT07047365

This clinical trial is studying a new drug called TQB2930, combined with chemotherapy, to treat advanced breast cancer that tests positive for a protein called HER2. The study will compare this new...

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT ID: NCT06625775

The BREAKER-101 clinical trial is a study looking at a new treatment called BBO-10203 for patients with advanced solid tumors, including certain types of breast and colorectal cancers. This is the ...

HER2 Molecular Imaging with 89Zr-trastuzumab PET/CT As a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients with Advanced HER2-positive Breast Cancer

NCT ID: NCT06595563

The ZEPHIR-02 clinical trial is designed to study a new imaging technique called HER2-PET/CT to help doctors decide on the best treatment options for patients with advanced HER2-positive breast can...

T-DM1 Combined With CDK4/6 Inhibitor Ribociclib

NCT ID: NCT06481956

DP303c in Patients With HER2-positive Advanced Breast Cancer

NCT ID: NCT05901935

This clinical trial is studying a new treatment called DP303c for patients with HER2-positive advanced breast cancer, which is a type of breast cancer that has spread and cannot be surgically remov...

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC

NCT ID: NCT05856383

This clinical trial is studying a new treatment approach for patients with HER2-positive advanced breast cancer, which is a specific type of breast cancer that tends to grow faster and can spread t...